How Pharmacists Evaluate Drug Interaction Alerts

Video

Daniel C. Malone, RPh, PhD, FAMCP, describes the methods pharmacists use to evaluate drug interaction alerts.

Daniel C. Malone, RPh, PhD, FAMCP, a professor of pharmacy at the University of Arizona College of Pharmacy, describes the methods pharmacists use to evaluate drug interaction alerts.

This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.

Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image credit: Andrea Izzotti
Human brain digital illustration. Electrical activity, flashes, and lightning on a blue background. | Image Credit: Siarhei - stock.adobe.com
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii | stock.adobe.com
Pharmacy Interior | Image Credit: Tyler Olson - stock.adobe.com
Male pharmacist selling medications at drugstore to a senior woman customer | Image Credit: Zamrznuti tonovi - stock.adobe.com
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen | stock.adobe.com
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store - Image credit: C Daniels/peopleimages.com | stock.adobe.com
Image credit: fidaolga - stock.adobe.com
Pharmacists checking inventory at hospital pharmacy- Image credit: Jacob Lund | stock.adobe.com
Related Content

Children Remain High Risk for Antiphospholipid Syndrome

November 23rd 2023

Pharmacy Focus: Conversations On Reproductive Health - Episode 1

November 15th 2023

Study: Pneumococcal Vaccines Do Not Prevent Development of Otitis Media in Infants

November 22nd 2023

Pharmacy Focus: Policy Edition - Navigating the Reimbursement Maze

November 13th 2023

CDC, FDA Announce 77,000 Additional Doses for Nirsevimab as Infant Treatment of RSV

November 22nd 2023

Pneumococcal Conjugate Vaccines Reduce Invasive Disease, Though Coverage Not Optimal

November 22nd 2023

Children Remain High Risk for Antiphospholipid Syndrome

November 23rd 2023

Pharmacy Focus: Conversations On Reproductive Health - Episode 1

November 15th 2023

Study: Pneumococcal Vaccines Do Not Prevent Development of Otitis Media in Infants

November 22nd 2023

Pharmacy Focus: Policy Edition - Navigating the Reimbursement Maze

November 13th 2023

CDC, FDA Announce 77,000 Additional Doses for Nirsevimab as Infant Treatment of RSV

November 22nd 2023

Pneumococcal Conjugate Vaccines Reduce Invasive Disease, Though Coverage Not Optimal

November 22nd 2023

Children Remain High Risk for Antiphospholipid Syndrome

November 23rd 2023

Pharmacy Focus: Conversations On Reproductive Health - Episode 1

November 15th 2023

Study: Pneumococcal Vaccines Do Not Prevent Development of Otitis Media in Infants

November 22nd 2023

Pharmacy Focus: Policy Edition - Navigating the Reimbursement Maze

November 13th 2023

CDC, FDA Announce 77,000 Additional Doses for Nirsevimab as Infant Treatment of RSV

November 22nd 2023

Pneumococcal Conjugate Vaccines Reduce Invasive Disease, Though Coverage Not Optimal

November 22nd 2023
© 2023 MJH Life Sciences

All rights reserved.